Zenith® TXD
DeviceZenith® TXD Dissection Stent Graft System for treatment of patients with aortic dissection of the descending thoracic aorta
NCT Number: NCT02663739
The study is a post-market surveillance study required by Japanese Regulatory Authorities as a condition of approval
Looking for future studies?
Notify MeAll sexes
Observational
Kokura Memorial Hospital, Fukuoka, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Zenith® TXD Dissection Stent Graft System for treatment of patients with aortic dissection of the descending thoracic aorta
Time frame: 5 years
Major adverse events will include death, aortic rupture, conversion to open surgical repair, spinal cord ischemia, retrograde progression of dissection, myocardial infarction, renal failure requiring dialysis, intestinal ischemia, stroke, paraplegia, and > 72 hours artificial respiratory assistance.
Cook Group Incorporated
Industry
Zenith TXD Dissection Stent Graft System Usage Results Surveillance in Japan for Treating Acute Complicated Stanford Type B Aortic Dissection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01568320
Acute Aortic Syndrome, Aneurysm
Los Angeles, California, United States
View Trial DetailsNCT02094300
Acute Aortic Syndrome, Aneurysm
Gainesville, Florida, United States
View Trial DetailsNCT04014972
Acute Aortic Syndrome, Aneurysm
View Trial DetailsNCT02380716
Acute Aortic Syndrome, Aneurysm
Los Angeles, California, United States
View Trial Details